This is a great interview with our CEO, Liz Dallimore.
"To develop a neuroprotective therapy for stroke is the Holy Grail of biotech."
- Forums
- ASX - By Stock
- New interview with CEO Liz Dallimore
AGN
argenica therapeutics limited
Add to My Watchlist
0.00%
!
31.5¢

This is a great interview with our CEO, Liz Dallimore."To...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
31.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.74M |
Open | High | Low | Value | Volume |
31.5¢ | 32.5¢ | 31.5¢ | $5.359K | 16.96K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 7376 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.0¢ | 35000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 349 | 0.315 |
5 | 8089 | 0.310 |
4 | 11910 | 0.305 |
5 | 77545 | 0.300 |
1 | 20000 | 0.295 |
Price($) | Vol. | No. |
---|---|---|
0.320 | 35000 | 1 |
0.330 | 20000 | 1 |
0.335 | 56153 | 2 |
0.345 | 65555 | 1 |
0.350 | 35901 | 3 |
Last trade - 11.20am 16/09/2025 (20 minute delay) ? |
Featured News
AGN (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online